Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NutriBand (NTRB) Cash & Equivalents (2018 - 2025)

NutriBand's Cash & Equivalents history spans 8 years, with the latest figure at $5.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 6.77% year-over-year to $5.3 million; the TTM value through Oct 2025 reached $5.3 million, down 6.77%, while the annual FY2025 figure was $4.3 million, 774.69% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $5.3 million at NutriBand, down from $7.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $8.3 million in Q2 2024 and bottomed at $151993.0 in Q1 2021.
  • The 5-year median for Cash & Equivalents is $3.2 million (2022), against an average of $3.5 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 3118.48% in 2022 before it crashed 75.17% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $5.5 million in 2021, then tumbled by 48.66% to $2.8 million in 2022, then plummeted by 55.07% to $1.3 million in 2023, then surged by 350.33% to $5.7 million in 2024, then dropped by 6.77% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for NTRB's Cash & Equivalents are $5.3 million (Q4 2025), $7.0 million (Q3 2025), and $3.0 million (Q2 2025).